217 related articles for article (PubMed ID: 24842412)
1. Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.
Huang K; Li LA; Meng YG; You YQ; Fu XY; Song L
Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):507-11. PubMed ID: 24842412
[TBL] [Abstract][Full Text] [Related]
2. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
3. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway.
Zhao F; Wang L; Liu K
J Ethnopharmacol; 2009 Apr; 122(3):457-62. PubMed ID: 19429312
[TBL] [Abstract][Full Text] [Related]
4. Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway.
Kou X; Qi S; Dai W; Luo L; Yin Z
Int Immunopharmacol; 2011 Aug; 11(8):1095-102. PubMed ID: 21426947
[TBL] [Abstract][Full Text] [Related]
5. Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
Wang HQ; Jin JJ; Wang J
J Biochem Mol Toxicol; 2014 Jan; 28(1):39-45. PubMed ID: 24395429
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines.
Susanti S; Iwasaki H; Inafuku M; Taira N; Oku H
Phytomedicine; 2013 Dec; 21(1):39-46. PubMed ID: 24021157
[TBL] [Abstract][Full Text] [Related]
7. Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy.
Feng T; Cao W; Shen W; Zhang L; Gu X; Guo Y; Tsai HI; Liu X; Li J; Zhang J; Li S; Wu F; Liu Y
Oncotarget; 2017 Jan; 8(1):329-344. PubMed ID: 27861147
[TBL] [Abstract][Full Text] [Related]
8. Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling.
Yoo JH; Lee HJ; Kang K; Jho EH; Kim CY; Baturen D; Tunsag J; Nho CW
Food Chem Toxicol; 2010; 48(8-9):2247-52. PubMed ID: 20510325
[TBL] [Abstract][Full Text] [Related]
9. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway.
Janthamala S; Jusakul A; Kongpetch S; Kimawaha P; Klanrit P; Loilome W; Namwat N; Techasen A
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2049-2059. PubMed ID: 34283274
[TBL] [Abstract][Full Text] [Related]
10. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition.
Cho MK; Jang YP; Kim YC; Kim SG
Int Immunopharmacol; 2004 Oct; 4(10-11):1419-29. PubMed ID: 15313439
[TBL] [Abstract][Full Text] [Related]
11. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
Engels K; Knauer SK; Loibl S; Fetz V; Harter P; Schweitzer A; Fisseler-Eckhoff A; Kommoss F; Hanker L; Nekljudova V; Hermanns I; Kleinert H; Mann W; du Bois A; Stauber RH
Cancer Res; 2008 Jul; 68(13):5159-66. PubMed ID: 18593915
[TBL] [Abstract][Full Text] [Related]
12. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
16. Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity.
Yao X; Li G; Lü C; Xu H; Yin Z
Int Immunopharmacol; 2012 Oct; 14(2):138-44. PubMed ID: 22770942
[TBL] [Abstract][Full Text] [Related]
17. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Zhao X; Guo X; Shen J; Hua D
Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
[TBL] [Abstract][Full Text] [Related]
18. The effects of arctigenin on human rheumatoid arthritis fibroblast-like synoviocytes.
Liu H; Yang Y; Cai X; Gao Y; Du J; Chen S
Pharm Biol; 2015 Aug; 53(8):1118-23. PubMed ID: 25609147
[TBL] [Abstract][Full Text] [Related]
19. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis.
Yang S; Ma J; Xiao J; Lv X; Li X; Yang H; Liu Y; Feng S; Zhang Y
Anat Rec (Hoboken); 2012 Aug; 295(8):1260-6. PubMed ID: 22619087
[TBL] [Abstract][Full Text] [Related]
20. Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells.
Jeong JB; Hong SC; Jeong HJ; Koo JS
Int Immunopharmacol; 2011 Oct; 11(10):1573-7. PubMed ID: 21621647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
